HR+ HER2- Early Breast Cancer

HR+ HER2- Early Breast Cancer

From Fatigue to Function: Unpacking Multidriver Symptom Clusters in Early-Stage Breast Cancer

patient care perspectives
By Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer

clinical topic updates
By Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

The Multidisciplinary Care of Patients With Early-Stage Breast Cancer

patient care perspectives
By Ian Krop, MD, PhD

HR+ HER2- Early Breast Cancer

Surveillance Expectations for Early-Stage Breast Cancer

patient care perspectives
By Virginia Kaklamani, MD, DSc

HR+ HER2- Early Breast Cancer

Adjuvant CDK4/6 Inhibitors for HR+/HER2- Early-Stage Breast Cancer: Who Should Get Them and How Toxicity Should Be Managed

clinical topic updates
By Ian Krop, MD, PhD